Thynk Health

The Thynk Health platform optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives.

ThynkHealth - Riverain

Thynk Health and Riverian Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies

Media Releases / By

12/1/2022, Lexington, KY: Thynk Health and Riverain, pioneers in the healthcare artificial intelligence space, have announced a partnership between their platforms to fight lung cancer with the world’s most advanced technologies. Combining all the latest technologies, including CAD, Machine Learning, clinical NLP, recurrent neural networks, and artificial intelligence, this partnership offers an unprecedented opportunity for lung […]

Thynk Health and Riverian Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies Read More »

JONS: Identifying Best Practices and Gaps in Early-Stage Lung Cancer

News / By

Download PDF Thynk Health’s Vice President of Strategic Partnerships & Clinical Liaison, Kim Parham, RN, BSN, CN-BN contributed to the following article in the Journal of Oncology, Navigation and Survivorship. Identifying Best Practices and Gaps in Early-Stage Lung Cancer: From Screening and Early Detection Through Resectable Disease Treatment February 2022 Vol 13, No 2 Lung

JONS: Identifying Best Practices and Gaps in Early-Stage Lung Cancer Read More »

Thynk Health Automates the Tracking and Management of Incidental Findings Across Major Organs

Media Releases / By

May 10, 2021 – Lexington, KY: Thynk Health is transforming cancer screening and incidental findings management with the state-of-the-art Enterprise Incidental Findings Tracker.  In the United States, approximately 1.9 million new cancer cases are expected to be diagnosed in 2021 alone. While healthcare systems offer some of the most advanced treatments for cancer in the

Thynk Health Automates the Tracking and Management of Incidental Findings Across Major Organs Read More »

Physician Examining CT Scan

Build and Grow Your Lung Cancer Screening Management Program

White Paper / By

Download White Paper PDF Abstract In 2019, 142,670 Americans died of lung cancer— more than colorectal, breast and prostate cancer combined. Lung cancer remains the leading cause of cancer death. However, according to the American Lung Association (ALA), only 5.7 percent of the estimated 15 million eligible Americans at risk of developing lung cancer will

Build and Grow Your Lung Cancer Screening Management Program Read More »

Lung Cancer Screenings Could Double, Is Your Program Prepared?

Lung Cancer Screenings Could Double, Is Your Program Prepared?

Blogs / By

Lung Cancer Screenings Could Double, Is Your Program Prepared? The United State Preventive Services Task Force (USPSTF) issued new guidance on lung cancer screening that could make a significant impact, possibly even saving an additional 60,000 people annually. Lung cancer continues to be the second most common cancer and the leading cause of cancer death

Lung Cancer Screenings Could Double, Is Your Program Prepared? Read More »

White Paper - Incidental Findings Management: Protecting Patients, Providers, & Healthcare Systems

White Paper: Incidental Findings Management: Protecting Patients, Providers, & Healthcare Systems

White Paper / By

DOWNLOAD PDF Incidental findings: Results that arise that are outside the original purpose for which the test or procedure was conducted. Overview As imaging technology continues to advance, anomalies are increasingly more detectable, making incidental findings more commonplace. Recent systematic reviews (1) noted the mention of these findings in radiology reports is as high as

White Paper: Incidental Findings Management: Protecting Patients, Providers, & Healthcare Systems Read More »

Thynk Health and InferVision Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies

Media Releases / By

Thynk Health and InferVision Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies [02/10/2021], Lexington, KY: Thynk Health and Infervision, pioneers in the healthcare artificial intelligence space, have announced a partnership between their platforms to fight lung cancer with the world’s most advanced technologies. By combining AI-driven data and analytics abstracted from EHRs

Thynk Health and InferVision Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies Read More »

Mercy One Des Moines Case Study

Case Study: MercyOne Des Moines Lung Cancer Screening

Case Studies / By

DOWNLOAD PDF As one of 100 great hospitals in the U.S. according to Becker’s Healthcare, MercyOne Des Moines Medical Center is among the nation’s high-performing hospitals, recognized for excellence in clinical care, patient outcomes and staff and physician satisfaction. One of central Iowa’s largest multi-specialty clinic systems, MercyOne is made up of more than 50

Case Study: MercyOne Des Moines Lung Cancer Screening Read More »

Thynk Health Partners with MercyOne Des Moines to Empower Lung Screening

Thynk Health Solution Empowers MercyOne Des Moines to Grow Lung Screening Program

Media Releases / By

MercyOne Des Moines Increases New Patient Lung Cancer Screenings by 76.2% in the First Year [09/24/2020], Lexington, KY: Lung Cancer accounts for 25 percent of cancer-related deaths in the U.S. and causes more deaths than the next three cancers combined. Yet, lung cancer screening rates remain some of the lowest. Empowered by Thynk Health’s complete

Thynk Health Solution Empowers MercyOne Des Moines to Grow Lung Screening Program Read More »

Scroll to Top